Gene News and Research

Latest Gene News and Research

SARS-CoV-2 infection in coronary vessels linked to cardiovascular complications

Researchers reported that the increased long-term risk of acute cardiovascular complications associated with COVID-19 is linked to SARS-CoV-2 infecting coronary vessels and inducing the formation of plaques.

3 Oct 2023

Microglial states and their impact on Alzheimer's disease

Researchers examined 152,459 microglial transcriptomes from 443 individuals, identifying 12 transcriptional states and their relationship to Alzheimer's disease.

3 Oct 2023

Identification of Alzheimer's disease-associated micro-RNA biomarkers through network-based analysis

Micro-ribonucleic acids (miRNAs) linked to cognition and Alzheimer's disease (AD).

3 Oct 2023

Could seaweeds be the superfood and medicine of the future?

Researchers consolidate the diverse nutritional and medicinal benefits of seaweeds, touting their potential in food, nutraceuticals, and pharmaceuticals. The study also highlights challenges and opportunities in industrial applications, calling for more research to optimize extraction and refinement processes.

2 Oct 2023

Eat by the clock: How meal timing tunes your liver's circadian rhythm

A study in Nature Communications delves into how the liver's circadian clock responds to meal timing, impacting fat metabolism and other bodily processes. The research underscores the intricate network that contributes to liver's diurnal rhythms, regulated by protein phosphorylation and nutrient availability.

2 Oct 2023

A better method to predict polygenic inheritance across multiple ancestries

Researchers report the results obtained from the use of a new PRS calculator called CT-SLEB on a multi-national GWAS database.

2 Oct 2023

Mogrify extends Series A financing to $46 million USD

Mogrify Limited (Mogrify®), a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, announced today an additional $10 million USD closing of its Series A financing.

From Mogrify 2 Oct 2023

Evonetix unveils new branding to align with its vision for gene-length DNA synthesis

EVONETIX LTD (‘Evonetix’) today announces the introduction of new branding.

From Evonetix 2 Oct 2023

Broken String Biosciences strengthens senior leadership team to accelerate product development and commercialization

Broken String Biosciences, a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today announced the expansion of its senior leadership team.

From Broken String Biosciences 2 Oct 2023

New study reveals alarming cardiovascular risks from COVID

The study published in Nature Cardiovascular Research reveals that SARS-CoV-2, the virus causing COVID-19, can directly infect coronary vessels and arterial plaques, heightening the risk of cardiovascular complications like heart attacks and strokes. These findings offer critical insights into the increased long-term cardiovascular risks for COVID-19 survivors and open new avenues for targeted therapies.

1 Oct 2023

Can catching some rays help you fight off type 2 diabetes?

Natural light exposure could help improve blood sugar control in individuals with type 2 diabetes, according to a new study presented at the EASD meeting. The research suggests that natural daylight positively affects metabolic functions, potentially aiding in the treatment and prevention of metabolic diseases.

1 Oct 2023

Could plant-based phytonutrients be the secret weapon against obesity?

This comprehensive review in the journal Foods explores the therapeutic potential of phytonutrients in combating obesity. The paper delves into various plant-based compounds like polyphenols, alkaloids, and terpenoids, detailing their mechanisms of action in inhibiting fat accumulation, regulating metabolism, and even altering gut microbiota.

1 Oct 2023

Killer T cells in older adults found to be less effective at fighting influenza viruses

A world-first discovery has revealed special immune cells called ‘killer T cells’ in older adults, directed against influenza viruses, closely resemble those found in newborns and children, but struggle to recognise infected cells – a finding that unlocks the potential for the development of better vaccines and therapies tailored to different age groups.

30 Sep 2023

Study shows consanguinity may raise risk of type 2 diabetes and other common diseases

A new study finds that consanguinity – unions between close relatives – may increase the risk of common diseases such as type 2 diabetes and post-traumatic stress disorder (PTSD).

30 Sep 2023

Cancer cells hijack enhancer DNA to grow faster, study finds

University of Toronto researchers have found that cancer cells can enhance tumor growth by hijacking enhancer DNA normally used when tissues and organs are formed.

29 Sep 2023

New drug could transform how doctors treat grade 2 IDH-mutant gliomas

A top UVA Health cancer expert is highlighting how a new drug could transform how doctors treat a brain tumor that typically strikes younger people.

29 Sep 2023

New CRISPR-based gene-editing tool could lead to better treatments for genetic disorders

A new CRISPR-based gene-editing tool has been developed which could lead to better treatments for patients with genetic disorders.

29 Sep 2023

Study shows how tumors "hijack" genetic program used by developing nerves

Cancer tumors "hijack" the genetic program used by developing nerves. This is shown in a study by researchers at Umeå University, Sweden.

29 Sep 2023

New artemisinin-resistant malaria parasite detected in Eritrea

Diagnosis of Plasmodium falciparum malaria using rapid diagnostic tests and treatment with artemisinin derivatives, the main component of the malaria treatments recommended by the World Health Organization (WHO), are under threat in the Horn of Africa.

29 Sep 2023

Parasites that cause visceral leishmaniasis can infect non-immune cells, study finds

The organisms that cause visceral leishmaniasis, a potentially deadly version of the parasitic disease that most often affects the skin to cause disfiguring disease, appear to have a secret weapon, new research suggests: They can infect non-immune cells and persist in those uncommon environments.

29 Sep 2023

Gene News and Research

Latest Gene News and Research

SARS-CoV-2 infection in coronary vessels linked to cardiovascular complications

Microglial states and their impact on Alzheimer's disease

Identification of Alzheimer's disease-associated micro-RNA biomarkers through network-based analysis

Could seaweeds be the superfood and medicine of the future?

Eat by the clock: How meal timing tunes your liver's circadian rhythm

A better method to predict polygenic inheritance across multiple ancestries

Mogrify extends Series A financing to $46 million USD

Evonetix unveils new branding to align with its vision for gene-length DNA synthesis

Broken String Biosciences strengthens senior leadership team to accelerate product development and commercialization

New study reveals alarming cardiovascular risks from COVID

Can catching some rays help you fight off type 2 diabetes?

Could plant-based phytonutrients be the secret weapon against obesity?

Killer T cells in older adults found to be less effective at fighting influenza viruses

Study shows consanguinity may raise risk of type 2 diabetes and other common diseases

Cancer cells hijack enhancer DNA to grow faster, study finds

New drug could transform how doctors treat grade 2 IDH-mutant gliomas

New CRISPR-based gene-editing tool could lead to better treatments for genetic disorders

Study shows how tumors "hijack" genetic program used by developing nerves

New artemisinin-resistant malaria parasite detected in Eritrea

Parasites that cause visceral leishmaniasis can infect non-immune cells, study finds

eBook: Using iPSCs models for human disease research and drug discovery eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research